Tom Haywood
British Patient Capital
Tom manages the direct co-investment programme at British Patient Capital. Prior to joining British Patient Capital, he was an investor at Foresight Group and EcoMachines Ventures before that. Earlier in his career he co-founded a biotech manufacturing startup called Puridify that sold to GE Healthcare and worked in investment banking at Deutsche Bank. He holds an MBA from London Business School and is a CFA Charterholder.
Eric Hirschhorn
Bank of New York Mellon
Martha Cummings
Paola Bergamaschi Broyd
Simon Collins
Annabelle Bexiga
Edwin van Bommel
ABN AMRO Ventures
Julian Johnson
Miki Edelman
Adam Markson
Accenture
Lord Jonathan Evans
You may also be interested in…
A Guide to Creating Personalized Digital Services in Insurance
Learn how to leverage the power of AI and Advanced Analytics to manage changing customer expectations – and thrive in the digital age.
Quantexa’s Anastasia Petrova and Sheryl Wharff Named on CRN’s 2022 Women of the Channel List
CRN names Quantexa’s Anastasia Petrova and Sheryl Wharff to its Women of the Channel list for 2022. Find out more here.
Scams: You Can Prevent More Than You Think
Learn how you can tackle the rising tide of internet-enabled crime by leveraging the power of advanced analytics technology.
Transforming KYC Investigations with ABN AMRO [Video]
In this video, unlock the impressive results ABN AMRO reaped by deploying Quantexa’s advanced technology solution into their KYC processes.
Celent Report: Quantexa’s Contextual Monitoring Solution
Discover how Quantexa’s Contextual Monitoring approach is revolutionizing traditional transaction monitoring in this exclusive report.
3 Ways a Contextual KYC Approach Can Help Improve Customer Onboarding and Refresh
Explore how a contextual approach to customer onboarding and refresh is key to detecting financial crime risk.